Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial

Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial

Background: House dust mite (HDM)-induced allergic rhinitis (AR) is a major cause of allergic respiratory disease. The efficacy and safety of the 300 IR HDM sublingual immunotherapy (SLIT) tablet in patients with moderate-to-severe HDM-AR was confirmed in a large, international, phase 3 randomized c...

Full description

Bibliographic Details
Main Authors: Oliver Pfaar, MD, PhD, Frédéric De BLAY, MD, Giorgio Walter Canonica, MD, Thomas B. Casale, MD, PhD, Philippe Gevaert, MD, PhD, Peter W. Hellings, MD, PhD, Krzysztof Kowal, MD, PhD, Giovanni Passalacqua, MD, Miguel Tortajada-Girbés, MD, PhD, Carmen Vidal, MD, PhD, Margitta Worm, MD, PhD, Farah Bahbah, MD, Pascal Demoly, MD, PhD
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:World Allergy Organization Journal
Subjects:
Allergic rhinitis
Combined score
House dust mite
Quality of life
Sublingual immunotherapy tablet
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455123001096

Internet

http://www.sciencedirect.com/science/article/pii/S1939455123001096

Similar Items